Medtronic director granted 1,444 share stock award

Groetelaars John P reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Groetelaars John P reported acquisition or exercise transactions in this Form 4 filing.

Medtronic plc director John P. Groetelaars received a stock award rather than buying shares on the market. He was granted 1,444 ordinary shares on a Form 4 report, at a stated price of $0.00 per share, as compensation.

The award represents restricted stock units that vest on the one-year anniversary of the grant date, so he must remain eligible through that period to receive the shares. Following this grant, his directly held position reported in this filing is 1,444 ordinary shares, reflecting a small, routine equity award for a board member.

Insider Trade Summary

Grant/Award: 1,444 shares

Grant/Award 1 txn

Insider Groetelaars John P

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Ordinary Shares	1,444	$0.00	$0.00

Holdings After Transaction: Ordinary Shares — 1,444 shares (Direct)

Footnotes (1)

1. F1. Represents an award of restricted stock units that vest on the one-year anniversary of the award date.

Key Figures

Shares granted: 1,444 shares Grant price per share: $0.00 per share Shares held after grant: 1,444 shares

3 metrics

Shares granted 1,444 shares Grant of Medtronic ordinary shares reported on Form 4

Grant price per share $0.00 per share Compensation-related stock award, not an open-market purchase

Shares held after grant 1,444 shares Direct ownership position for John P. Groetelaars following the award

Key Terms

restricted stock units, Grant, award, or other acquisition, Ordinary Shares

3 terms

restricted stock units financial

"Represents an award of restricted stock units that vest on the one-year anniversary"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

Ordinary Shares financial

"security_title: "Ordinary Shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the latest Form 4 for Medtronic (MDT) show for John P. Groetelaars?

The Form 4 shows director John P. Groetelaars received an equity award of 1,444 Medtronic ordinary shares. These were granted as compensation, not bought in the open market, and are structured as restricted stock units that vest after one year.

How many Medtronic (MDT) shares were granted to director John P. Groetelaars?

John P. Groetelaars was granted 1,444 Medtronic ordinary shares. The Form 4 reports a transaction price of $0.00 per share, indicating a compensation-related grant rather than a cash purchase, and shows his direct holdings as 1,444 shares after the award.

What is the vesting schedule for John P. Groetelaars’ Medtronic (MDT) restricted stock units?

The award consists of restricted stock units that vest on the one-year anniversary of the award date. This means Groetelaars must remain eligible for a full year before the units convert into Medtronic ordinary shares that he fully owns.

Was John P. Groetelaars’ Medtronic (MDT) Form 4 transaction an open-market purchase?

No. The Form 4 reports a grant coded as a "Grant, award, or other acquisition" with a $0.00 price per share. This indicates a compensation-related stock award, not an open-market purchase where the director paid cash for Medtronic shares.

How did the equity award affect John P. Groetelaars’ Medtronic (MDT) share ownership?

Following the grant, John P. Groetelaars is reported as directly holding 1,444 Medtronic ordinary shares. The filing does not list other holdings, so this equity award establishes his current reported direct ownership position from this specific Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/29/2026 - 04:13 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Groetelaars John P

(Last) (First) (Middle)

C/O MEDTRONIC

710 MEDTRONIC PARKWAY

(Street)

MINNEAPOLIS MINNESOTA 55432

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Medtronic plc [ MDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	04/27/2026		A		1,444(1)	A	$0	1,444	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of restricted stock units that vest on the one-year anniversary of the award date.

Remarks:

	/s/ Patricia Walesiewicz, attorney-in-fact	04/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)